These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30410684)

  • 1. General synthesis of silica-based yolk/shell hybrid nanomaterials and
    Chen F; Goel S; Shi S; Barnhart TE; Lan X; Cai W
    Nano Res; 2018 Sep; 11(9):4890-4904. PubMed ID: 30410684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiolabeling Silica-Based Nanoparticles via Coordination Chemistry: Basic Principles, Strategies, and Applications.
    Ni D; Jiang D; Ehlerding EB; Huang P; Cai W
    Acc Chem Res; 2018 Mar; 51(3):778-788. PubMed ID: 29489335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vivo Tumor-Targeted Dual-Modality PET/Optical Imaging with a Yolk/Shell-Structured Silica Nanosystem.
    Shi S; Chen F; Goel S; Graves SA; Luo H; Theuer CP; Engle JW; Cai W
    Nanomicro Lett; 2018; 10(4):65. PubMed ID: 30393713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo tumor targeting and image-guided drug delivery with antibody-conjugated, radiolabeled mesoporous silica nanoparticles.
    Chen F; Hong H; Zhang Y; Valdovinos HF; Shi S; Kwon GS; Theuer CP; Barnhart TE; Cai W
    ACS Nano; 2013 Oct; 7(10):9027-39. PubMed ID: 24083623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering Intrinsically Zirconium-89 Radiolabeled Self-Destructing Mesoporous Silica Nanostructures for In Vivo Biodistribution and Tumor Targeting Studies.
    Goel S; Chen F; Luan S; Valdovinos HF; Shi S; Graves SA; Ai F; Barnhart TE; Theuer CP; Cai W
    Adv Sci (Weinh); 2016 Nov; 3(11):1600122. PubMed ID: 27980987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General route to multifunctional uniform yolk/mesoporous silica shell nanocapsules: a platform for simultaneous cancer-targeted imaging and magnetically guided drug delivery.
    Zhang L; Wang T; Yang L; Liu C; Wang C; Liu H; Wang YA; Su Z
    Chemistry; 2012 Sep; 18(39):12512-21. PubMed ID: 22907903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vivo Tumor Vasculature Targeting of CuS@MSN Based Theranostic Nanomedicine.
    Chen F; Hong H; Goel S; Graves SA; Orbay H; Ehlerding EB; Shi S; Theuer CP; Nickles RJ; Cai W
    ACS Nano; 2015; 9(4):3926-34. PubMed ID: 25843647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiolabeled, Antibody-Conjugated Manganese Oxide Nanoparticles for Tumor Vasculature Targeted Positron Emission Tomography and Magnetic Resonance Imaging.
    Zhan Y; Shi S; Ehlerding EB; Graves SA; Goel S; Engle JW; Liang J; Tian J; Cai W
    ACS Appl Mater Interfaces; 2017 Nov; 9(44):38304-38312. PubMed ID: 29028311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesoporous titania based yolk-shell nanoparticles as multifunctional theranostic platforms for SERS imaging and chemo-photothermal treatment.
    Zhang W; Wang Y; Sun X; Wang W; Chen L
    Nanoscale; 2014 Nov; 6(23):14514-22. PubMed ID: 25347346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vivo Targeting and Positron Emission Tomography Imaging of Tumor with Intrinsically Radioactive Metal-Organic Frameworks Nanomaterials.
    Chen D; Yang D; Dougherty CA; Lu W; Wu H; He X; Cai T; Van Dort ME; Ross BD; Hong H
    ACS Nano; 2017 Apr; 11(4):4315-4327. PubMed ID: 28345871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography imaging using radiolabeled inorganic nanomaterials.
    Sun X; Cai W; Chen X
    Acc Chem Res; 2015 Feb; 48(2):286-94. PubMed ID: 25635467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target-or-Clear Zirconium-89 Labeled Silica Nanoparticles for Enhanced Cancer-Directed Uptake in Melanoma: A Comparison of Radiolabeling Strategies.
    Chen F; Ma K; Zhang L; Madajewski B; Zanzonico P; Sequeira S; Gonen M; Wiesner U; Bradbury MS
    Chem Mater; 2017 Oct; 29(19):8269-8281. PubMed ID: 29123332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yolk-Shell Nanostructure: An Ideal Architecture to Achieve Harmonious Integration of Magnetic-Plasmonic Hybrid Theranostic Platform.
    Lin LS; Yang X; Zhou Z; Yang Z; Jacobson O; Liu Y; Yang A; Niu G; Song J; Yang HH; Chen X
    Adv Mater; 2017 Jun; 29(21):. PubMed ID: 28328150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
    Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
    Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonsacrificial Template Synthesis of Magnetic-Based Yolk-Shell Nanostructures for the Removal of Acetaminophen in Fenton-like Systems.
    Do QC; Kim DG; Ko SO
    ACS Appl Mater Interfaces; 2017 Aug; 9(34):28508-28518. PubMed ID: 28771304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extraction-Induced Fabrication of Yolk-Shell-Structured Nanoparticles with Deformable Micellar Cores and Mesoporous Silica Shells for Multidrug Delivery.
    Niu D; Jiang Y; He J; Jia X; Qin L; Hao J; Zhao W; Dai B; Li Y
    ACS Appl Bio Mater; 2019 Dec; 2(12):5707-5716. PubMed ID: 35021564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Transformation of Hybrid Silica Nanoparticles from Solid to Hollow or Yolk-Shell Nanostructures.
    Liu X; Qian G; Jiao Z; Wu M; Zhang H
    Chemistry; 2017 Jun; 23(33):8066-8072. PubMed ID: 28432799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theragnostic potentials of core/shell mesoporous silica nanostructures.
    Ravindran Girija A; Balasubramanian S
    Nanotheranostics; 2019; 3(1):1-40. PubMed ID: 30662821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silica-based organic-inorganic hybrid nanoparticles and nanoconjugates for improved anticancer drug delivery.
    Ilhan-Ayisigi E; Yesil-Celiktas O
    Eng Life Sci; 2018 Dec; 18(12):882-892. PubMed ID: 32624882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hollow mesoporous silica nanoparticles for tumor vasculature targeting and PET image-guided drug delivery.
    Chakravarty R; Goel S; Hong H; Chen F; Valdovinos HF; Hernandez R; Barnhart TE; Cai W
    Nanomedicine (Lond); 2015; 10(8):1233-46. PubMed ID: 25955122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.